Prophylaxis and immunotherapy of S. aureus/MRSA disease
Staphylococcus aureus (SA) is a Gram-positive bacterium that colonizes approximately one-third of the human population1. It causes a wide range of diseases from skin and soft tissue infections (SSTI) to life-threatening systemic diseases such as bacteremia and pneumonia with high mortality rates2,3. Currently, methicillin-resistant S. aureus (MRSA) is killing as many people…